Wednesday
May 7, 2025
7:05 AM ET
Ironwood Pharmaceuticals Reports First Quarter 2025 Results
Friday
April 25, 2025
7:05 AM ET
Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance
Thursday
February 27, 2025
7:00 AM ET
Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance
Thursday
February 20, 2025
4:00 PM ET
Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call
Wednesday
January 29, 2025
4:05 PM ET
Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future